Concepts (106)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bacterial Toxins | 5 | 2013 | 176 | 0.670 |
Why?
|
| Antigens, Bacterial | 5 | 2013 | 324 | 0.620 |
Why?
|
| Heart | 3 | 2007 | 689 | 0.530 |
Why?
|
| Spironolactone | 2 | 2013 | 22 | 0.420 |
Why?
|
| Aldosterone | 2 | 2013 | 65 | 0.420 |
Why?
|
| Coronary Angiography | 2 | 2002 | 486 | 0.300 |
Why?
|
| Coronary Thrombosis | 1 | 2008 | 35 | 0.290 |
Why?
|
| Bradycardia | 1 | 2008 | 60 | 0.280 |
Why?
|
| Thrombectomy | 1 | 2008 | 112 | 0.270 |
Why?
|
| Viper Venoms | 1 | 2007 | 3 | 0.270 |
Why?
|
| Adenylyl Cyclases | 1 | 2007 | 67 | 0.260 |
Why?
|
| Shock | 1 | 2007 | 99 | 0.240 |
Why?
|
| Echocardiography | 3 | 2013 | 1126 | 0.220 |
Why?
|
| Hypertension | 1 | 2013 | 1398 | 0.220 |
Why?
|
| Coronary Vessels | 1 | 2008 | 549 | 0.210 |
Why?
|
| Rats | 6 | 2013 | 3607 | 0.210 |
Why?
|
| Cardiac Catheterization | 1 | 2008 | 671 | 0.210 |
Why?
|
| Heart Ventricles | 1 | 2007 | 785 | 0.190 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2013 | 1224 | 0.190 |
Why?
|
| Purpura, Thrombocytopenic, Idiopathic | 1 | 2002 | 54 | 0.180 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2002 | 150 | 0.170 |
Why?
|
| Myocardial Ischemia | 1 | 2002 | 341 | 0.150 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2002 | 289 | 0.140 |
Why?
|
| Integrins | 2 | 2009 | 94 | 0.140 |
Why?
|
| Heart Failure | 2 | 2010 | 2398 | 0.130 |
Why?
|
| Disease Models, Animal | 2 | 2010 | 4690 | 0.130 |
Why?
|
| Cardiovascular Diseases | 4 | 2009 | 2087 | 0.110 |
Why?
|
| Heart Failure, Diastolic | 1 | 2013 | 10 | 0.100 |
Why?
|
| Rats, Inbred WKY | 1 | 2013 | 48 | 0.100 |
Why?
|
| Rats, Inbred SHR | 1 | 2013 | 58 | 0.100 |
Why?
|
| Animals | 8 | 2013 | 34842 | 0.090 |
Why?
|
| Anthrax | 2 | 2009 | 31 | 0.090 |
Why?
|
| Calcium-Binding Proteins | 1 | 2013 | 333 | 0.090 |
Why?
|
| Ventricular Dysfunction | 1 | 2010 | 25 | 0.080 |
Why?
|
| Norepinephrine | 1 | 2010 | 166 | 0.080 |
Why?
|
| Counterpulsation | 1 | 2010 | 5 | 0.080 |
Why?
|
| Signal Transduction | 3 | 2013 | 4720 | 0.080 |
Why?
|
| Vasoconstrictor Agents | 1 | 2010 | 141 | 0.080 |
Why?
|
| Angina Pectoris | 1 | 2010 | 68 | 0.080 |
Why?
|
| Cardiovascular System | 1 | 2009 | 105 | 0.070 |
Why?
|
| Blood Flow Velocity | 2 | 2010 | 440 | 0.070 |
Why?
|
| Cardiovascular Agents | 1 | 2007 | 87 | 0.060 |
Why?
|
| Endothelial Cells | 1 | 2010 | 526 | 0.060 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2006 | 48 | 0.060 |
Why?
|
| Mineralocorticoid Receptor Antagonists | 1 | 2006 | 45 | 0.060 |
Why?
|
| Sepsis | 1 | 2010 | 516 | 0.060 |
Why?
|
| Extracellular Matrix | 1 | 2007 | 237 | 0.060 |
Why?
|
| Diastole | 1 | 2006 | 181 | 0.060 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2010 | 551 | 0.060 |
Why?
|
| Male | 8 | 2013 | 64979 | 0.060 |
Why?
|
| Endothelium, Vascular | 1 | 2007 | 486 | 0.050 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2006 | 305 | 0.050 |
Why?
|
| Apoptosis | 1 | 2010 | 1901 | 0.050 |
Why?
|
| Stroke Volume | 1 | 2006 | 536 | 0.050 |
Why?
|
| Echocardiography, Doppler | 1 | 2004 | 172 | 0.050 |
Why?
|
| Arteriosclerosis | 1 | 2003 | 123 | 0.050 |
Why?
|
| Reference Values | 1 | 2004 | 703 | 0.050 |
Why?
|
| Cell Proliferation | 1 | 2010 | 2511 | 0.050 |
Why?
|
| Humans | 13 | 2010 | 132201 | 0.050 |
Why?
|
| Time Factors | 2 | 2010 | 6452 | 0.050 |
Why?
|
| Electrocardiography | 1 | 2007 | 996 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2010 | 7123 | 0.040 |
Why?
|
| Ventricular Function, Left | 1 | 2004 | 548 | 0.040 |
Why?
|
| Lipids | 1 | 2003 | 561 | 0.040 |
Why?
|
| Aged | 3 | 2010 | 21456 | 0.040 |
Why?
|
| Coronary Artery Bypass | 1 | 2002 | 537 | 0.030 |
Why?
|
| Middle Aged | 3 | 2010 | 29007 | 0.030 |
Why?
|
| Risk Factors | 1 | 2008 | 10944 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2002 | 2165 | 0.030 |
Why?
|
| Female | 4 | 2010 | 70754 | 0.020 |
Why?
|
| Acute Disease | 1 | 2013 | 1163 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2008 | 17391 | 0.020 |
Why?
|
| Regenerative Medicine | 1 | 2010 | 35 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2013 | 1611 | 0.020 |
Why?
|
| Interleukin-10 | 1 | 2010 | 188 | 0.020 |
Why?
|
| Biomechanical Phenomena | 1 | 2010 | 229 | 0.020 |
Why?
|
| Spores, Bacterial | 1 | 2009 | 24 | 0.020 |
Why?
|
| Receptor Cross-Talk | 1 | 2009 | 36 | 0.020 |
Why?
|
| Bacillus anthracis | 1 | 2009 | 40 | 0.020 |
Why?
|
| Myocytes, Cardiac | 1 | 2013 | 652 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2010 | 666 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2010 | 880 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2013 | 3046 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2010 | 802 | 0.020 |
Why?
|
| Adult | 1 | 2008 | 31600 | 0.020 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2007 | 27 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 1554 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2009 | 472 | 0.020 |
Why?
|
| Consumer Product Safety | 1 | 2006 | 31 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2010 | 1444 | 0.010 |
Why?
|
| Hemodynamics | 1 | 2009 | 861 | 0.010 |
Why?
|
| Disease Progression | 1 | 2010 | 2230 | 0.010 |
Why?
|
| Apolipoprotein A-I | 1 | 2003 | 89 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2009 | 1402 | 0.010 |
Why?
|
| Apolipoproteins B | 1 | 2003 | 140 | 0.010 |
Why?
|
| Veins | 1 | 2003 | 101 | 0.010 |
Why?
|
| Amyloid | 1 | 2003 | 69 | 0.010 |
Why?
|
| Lipoproteins, LDL | 1 | 2003 | 133 | 0.010 |
Why?
|
| Lipoproteins, HDL | 1 | 2003 | 117 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2007 | 1250 | 0.010 |
Why?
|
| Arteries | 1 | 2003 | 221 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2006 | 1161 | 0.010 |
Why?
|
| C-Reactive Protein | 1 | 2003 | 464 | 0.010 |
Why?
|
| Triglycerides | 1 | 2003 | 617 | 0.010 |
Why?
|
| Cholesterol | 1 | 2003 | 559 | 0.010 |
Why?
|
| Biomarkers | 1 | 2003 | 3402 | 0.010 |
Why?
|